Multiple System Atrophy (MSA): Clinical Trials

1 trial for Multiple System Atrophy (MSA), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Active not recruiting 1

Follow Multiple System Atrophy (MSA): new trials by email Literature Review of Multiple System Atrophy (MSA) trials Research Report on Multiple System Atrophy (MSA)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase 2 Study of ONO-2808 in Patients With Multiple System Atrophy
ONO-2808, Placebo - Multiple System Atrophy (MSA)
Phase 2Active not recruitingOno Pharmaceutical Co., Ltd.922023-09-222026-10-06

Narrower conditions

Multiple System Atrophy (1)

Broader conditions

Autonomic Nervous System Diseases (1)  ·  Basal Ganglia Diseases (1)  ·  Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Movement Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurodegenerative Diseases (1)  ·  Primary Dysautonomias (1)  ·  Synucleinopathies (1)

Sponsors

Ono Pharmaceutical Co., Ltd. (1)

Countries

Japan (1)  ·  United States (1)

Top investigators

Project Leader (1)